Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Conatus Pharmaceuticals Inc. News

Count your blessings; bet on the banks: rev shark's best blog

Rev Shark steps in for Jim Cramer this week.

Futures point north, Asia mixed despite European attacks

Markets look set to continue their election rally as violence casts a pall over Europe.

Here's Why Conatus Pharmaceuticals (CNAT) Stock Is Soaring Today

Conatus Pharmaceuticals (CNAT) stock was boosted on Tuesday after Allergan (AGN) agreed to buy Tobira Therapeutics (TBRA) at a 500% premium.

Conatus Pharmaceuticals (CNAT) Stock Surges, Liver Drug Could Treat Zika

Conatus Pharmaceuticals' (CNAT) patented liver drug emricasan has been identified as a promising treatment for the Zika virus.

Conatus Pharmaceuticals (CNAT) Stock Soars on Positive Liver Drug Trial Results

Conatus Pharmaceuticals (CNAT) stock is increasing in mid-morning trading on Wednesday after the company said a Phase 2 trial of its liver drug showed positive results.

Breaking News

Robinhood Stock Surges, Then Halted, Amid Reports of FTX Takeover Interest

Sam Bankman-Fried's FTX is looking for a path to buy online brokerage group Robinhood, Bloomberg reported Monday.

General Electric Stock Gains As CEO Larry Culp Takes Over Aviation Division

"There is tremendous opportunity in aviation over the coming years, and the Board and I decided it is the right time for me to take on this expanded role," said GE CEO Larry Culp.

Feds Could Stop Trump SPAC Deal

An investigation by a federal grand jury could halt the proposed SPAC deal with Trump's social media company.

McDonald's Brings Back a Classic Menu Item (with a Catch)

You never know what the fast-food chain might bring back or create a new version of.